In all, our research provides a new mechanism underlying 3‐Cl‐AHPC anti‐cancer effect and a new strategy to antagonize matriptase activity through enhancing matriptase/HAI‐1 complex formation using small molecules. Here, SPINT1 is linked to cancer.